Using Imaris to rigorously track PET-defined sites of lung inflammation in Mycobacterium tuberculosis-exposed non-human primates

Authors

  • Estefania Hurtado Host-Pathogen Interactions (HPI) Program, Texas Biomedical Research Institute, San Antonio, TX, U.S. and Liberty University College of Osteopathic Medicine, Lynchburg, VA, U.S. Author
  • Xavier Alvarez Host-Pathogen Interactions (HPI) Program, Texas Biomedical Research Institute, San Antonio, TX, U.S. Author
  • Deepak Kaushal Host-Pathogen Interactions (HPI) Program, Texas Biomedical Research Institute, San Antonio, TX, U.S. and Disease Intervention and Prevention (DIP) Program, Texas Biomedical Research Institute, San Antonio, TX, U.S. Author
  • Smriti Mehra Host-Pathogen Interactions (HPI) Program, Texas Biomedical Research Institute, San Antonio, TX, U.S. and Disease Intervention and Prevention (DIP) Program, Texas Biomedical Research Institute, San Antonio, TX, U.S. Author
  • Vitaly V. Ganusov Host-Pathogen Interactions (HPI) Program, Texas Biomedical Research Institute, San Antonio, TX, U.S. Author

Keywords:

Imaging data, PET/CT, Imaris, SUV, radioactivity, PET tracers.

Abstract

Background: Aerosol exposure of non-human primates (NHPs) to Mycobacterium tuberculosis (Mtb) typically results in discrete sites of inflammation of the lung that is detectable by 2-deoxy2[fluorine-18]fluoro-D-glucose (18F-FDG)-based PET/CT scans. Such scans are often analyzed using software such as Invicro VivoQuant or OsiriX as 3D images by manual labeling sites of PET signal using 2D slices and by reporting maximal standardized uptake value (SUVmax) either of the whole lung or of individual lesions.

Methods: Here we propose a pipeline for analysis of the same PET/CT scans using Imaris, a proprietary software typically used for analysis of fluorescent microscopy data.

Results: We show that by using locations of spine vertebra (denoted as “landmarks”) we can align serials scans of the same animal, and by using automated (with some manual corrections) image segmentation of PET scans in 3D as “surfaces”, we can accurately define location of all sites of inflammation in the lung and lung-associated thoracic lymph nodes (LNs). We show that there is an excellent correlation between individual lesion’s SUVmax determined by VivoQuant and maximum intensity determined by Imaris suggesting utility of this approach. Imaris also provides wealth of additional information for each of the identified lesions such as volume, location, shape, surface area, and others, and each lesion can be exported in Virtual Reality file format (.wrl).

Conclusion: Our novel methodology allows for detailed and rigorous analyses of how features of PET-defined lesions in Mtb-exposed monkeys evolve over time and correlate with the outcome of infection and/or treatment.

Publication and Publisher Transfer Disclaimer: This article was originally published by WisdomGale Publishing, having its registered address at 14 Rue de Grand-Bigard, 1082 Brussels, Belgium. Following the formal transfer of publication rights and the subsequent change of publisher, the article was migrated to the publishing platform of International Medical Publishing Group (IMPG), India. The original publication details, authorship, and scholarly content remain unchanged. All subsequent publication management and archival responsibilities are administered by IMPG, India, in accordance with the terms and conditions of the publisher transfer agreement.

Downloads

Published

2026-11-03

Issue

Section

Articles

How to Cite

Using Imaris to rigorously track PET-defined sites of lung inflammation in Mycobacterium tuberculosis-exposed non-human primates. (2026). American Journal of Diagnostic Imaging (AJDI) (ISSN: 2577-2058), 12(Issue 2), 49-71. https://internationalmedicalpublishing.com/index.php/AJDI/article/view/416